These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5626257)

  • 1. [Clinical studies on the urinary excretion of aldosterone in myasthenia gravis].
    Nakamoto M
    Nihon Naibunpi Gakkai Zasshi; 1967 Nov; 43(8):770-84. PubMed ID: 5626257
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correlative dependance between excretion of catecholamines, corticosteroids and the metabolism of potassium and sodium in atherosclerosis].
    Furkalo NK
    Ter Arkh; 1968 Aug; 40(8):91-5. PubMed ID: 5747082
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adrenocortical function in myasthenia pseudoparalytica].
    Emeryk B; Rubach K; Barcikowski B; Kwiatkowska Z
    Neurol Neurochir Pol; 1976; 10(1):25-30. PubMed ID: 943707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenously administered chlorothiazide in diagnostic evaluation of hypertensive disease.
    McGuffin WL; Gunnells JC
    Arch Intern Med; 1969 Feb; 123(2):124-30. PubMed ID: 5763614
    [No Abstract]   [Full Text] [Related]  

  • 5. The syndrome of primary aldosteronism.
    George JM; Wright L; Bell NH; Bartter FC
    Am J Med; 1970 Mar; 48(3):343-56. PubMed ID: 5435648
    [No Abstract]   [Full Text] [Related]  

  • 6. Aldosterone, 17-hydroxycorticosteroid, 17-ketosteroid, and fluid and electrolyte responses to starvation and selective refeeding.
    Haag BL; Reidenberg MM; Shuman CR; Channick BJ
    Am J Med Sci; 1967 Nov; 254(5):652-8. PubMed ID: 6057075
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biochemical studies in myasthenia].
    Niebrój-Dobosz I; Kwiatkowska Z; Górecka A
    Neurol Neurochir Pol; 1970; 4(3):295-300. PubMed ID: 5455379
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of essential arterial hypertension with spironolactone: its value in the detection of primary hyperaldosteronism and prediction of its efficacy].
    Fournier A; Nakache JP; Salmon D; Kazandjian M; Baulon A; Legrand JC; Menard J; Lagrue G
    J Urol Nephrol (Paris); 1972 Dec; 78(12):1023-7. PubMed ID: 4661188
    [No Abstract]   [Full Text] [Related]  

  • 9. [MYASTHENIA GRAVIS].
    VAN HOVE
    Belg Tijdschr Geneesk; 1965 Jan; 21():81-4. PubMed ID: 14273382
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertension with inappropriate aldosterone stimulation.
    Christlieb AR; Hickler RB; Lauler DP; Williams GH
    N Engl J Med; 1969 Jul; 281(3):128-31. PubMed ID: 4307140
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
    Salti IS; Stiefel M; Ruse JL; Laidlaw JC
    Can Med Assoc J; 1969 Jul; 101(1):1-10. PubMed ID: 5793351
    [No Abstract]   [Full Text] [Related]  

  • 12. [Humoral disorders in hypertensive disease].
    Shtel'makh NI; Kamyshan NA; Ashcheulova IK; Gavrik TI
    Vrach Delo; 1973 Nov; 11():7-12. PubMed ID: 4786940
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary excretion of adrenal steroids, catecholamines and electrolytes in man, before and after acclimatization to cold in Antarctica.
    Budd GM; Warhaft N
    J Physiol; 1970 Nov; 210(4):799-806. PubMed ID: 5501486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary hypoaldosteronism caused by a probable anomaly of 18-hydroxylation].
    Jean R; Legrand JC; Meylan F; Rieu D; Astruc J
    Arch Fr Pediatr; 1969; 26(7):769-77. PubMed ID: 5355252
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of spironolactone on the excretion of C21-, C19-, and C18 steroids in pregnant and nonpregnant women].
    Nocke L; Breuer H; Klink R; Lichton IR; Nocke W
    Acta Endocrinol Suppl (Copenh); 1971; 152():41. PubMed ID: 5313553
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperplasia of the juxtaglomerular complex with secondary aldosteronism without hypertension (Bartter's syndrome).
    Brackett NC; Koppel M; Randall RE; Nixon WP
    Am J Med; 1968 May; 44(5):803-19. PubMed ID: 4297214
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of sodium homeostasis in children with recurrent urinary tract infections and reduced glomerular filtration rates.
    Aperia A; Berg U; Broberger O
    Acta Paediatr Scand; 1971 Nov; 60(6):695-704. PubMed ID: 5123499
    [No Abstract]   [Full Text] [Related]  

  • 18. URINARY 17-HYDROXYCORTICOSTEROIDS, 17-KETOSTEROIDS, PREGNANEDIOL AND PREGNANETRIOL IN PATIENTS WITH MYASTHENIA GRAVIS.
    TAKEDA Y; YOSHIDA S; UOZUMI T; NOZAKI R; KAJIMURA M
    Endocrinol Jpn; 1964 Sep; 11():237-44. PubMed ID: 14276654
    [No Abstract]   [Full Text] [Related]  

  • 19. 17-Ketosteroid excretion, myasthenia gravis, and breast cancer.
    Papatestas AE; Osserman KE; Kark AE
    Lancet; 1972 Mar; 1(7752):691-2. PubMed ID: 4125196
    [No Abstract]   [Full Text] [Related]  

  • 20. Catecholamine excretion in acromegalics.
    Marek J; Horký K; Kopecká J; Mĕstan J; Srámková J
    Endokrinologie; 1974 Sep; 63(3):304-11. PubMed ID: 4470080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.